# ZNF667

## Overview
ZNF667 is a gene that encodes the zinc finger protein 667, a member of the KRAB/C2H2 zinc-finger protein family, which is primarily involved in transcriptional repression. The protein is characterized by a KRAB domain and multiple C2H2-type zinc finger domains, which facilitate its role in binding specific DNA sequences to regulate gene expression (Chen2021ZNF667). Functionally, zinc finger protein 667 is implicated in the regulation of apoptosis and angiogenesis, notably by repressing pro-apoptotic genes and promoting angiogenic processes, particularly in response to myocardial ischemia (Wang2022ZNF667; Jiang2014ZNF667Mipu1). Clinically, alterations in ZNF667 expression have been associated with various cancers, where its downregulation is linked to poor prognosis, suggesting its potential role as a tumor suppressor (Meng2019Aberrant; Dong2019Aberrant).

## Structure
ZNF667, also known as zinc finger protein 667, is characterized by its molecular structure, which includes a KRAB domain at the N-terminus and 14 successive C2H2-type zinc finger domains at the C-terminus (Chen2021ZNF667). These structural features are typical of proteins that function as transcriptional repressors, allowing ZNF667 to bind to specific DNA sequences and regulate gene expression. The KRAB domain is known for its role in transcriptional repression, while the C2H2-type zinc finger domains facilitate DNA binding, which is crucial for the protein's function in gene regulation (Chen2021ZNF667).

The primary structure of ZNF667 is rich in cysteine and histidine residues, which form the zinc finger motifs. These motifs contribute to the secondary structure, which often includes alpha helices and beta sheets. The tertiary structure involves the folding of these motifs into a stable configuration, enabling the protein to interact with DNA and other proteins effectively. While the context does not provide specific details on the quaternary structure, it is common for zinc finger proteins to interact with other proteins, potentially forming complexes that influence their regulatory functions. The context does not mention any post-translational modifications or splice variant isoforms for ZNF667.

## Function
ZNF667, also known as Mipu1, is a zinc-finger protein that functions primarily as a transcriptional repressor in human cells. It is part of the KRAB/C2H2 zinc-finger superfamily and is predominantly active in the nucleus, where it binds to specific DNA sequences to regulate gene expression (Jiang2014ZNF667Mipu1). ZNF667 plays a significant role in inhibiting apoptosis by repressing the expression of pro-apoptotic genes such as Bax. It achieves this by binding to the Bax promoter, thereby reducing Bax mRNA and protein levels and preventing Bax translocation to mitochondria, which is crucial for the initiation of apoptosis (Jiang2014ZNF667Mipu1).

In the context of myocardial ischemia, ZNF667 facilitates angiogenesis by repressing the transcription of VASH1, a negative regulator of angiogenesis. This repression is potentially mediated through the Wnt signaling pathway, with ZNF667 influencing both canonical and non-canonical pathways (Wang2022ZNF667). The protein's role in angiogenesis and its anti-apoptotic functions highlight its importance in cellular survival and repair mechanisms, particularly in response to oxidative stress and ischemic conditions (Wang2022ZNF667; Jiang2014ZNF667Mipu1).

## Clinical Significance
Alterations in the expression of the ZNF667 gene have been implicated in various cancers, including laryngeal squamous cell carcinoma (LSCC) and esophageal squamous cell carcinoma (ESCC). In LSCC, both ZNF667 and its antisense transcript ZNF667-AS1 are downregulated, which is associated with poor pathological differentiation and survival rates. This downregulation is linked to hypermethylation of CpG regions near their transcriptional start sites, suggesting an epigenetic mechanism of silencing. Overexpression of these genes reduces the expression of epithelial-mesenchymal transition (EMT) markers, indicating their potential role as tumor suppressors by inhibiting cancer progression (Meng2019Aberrant).

In ESCC, ZNF667 and ZNF667-AS1 are also significantly downregulated, with their low expression correlating with advanced tumor stages and poor prognosis. The hypermethylation of their promoter regions is a key factor in their inactivation, and treatment with demethylating agents can restore their expression. This suggests that the methylation status of these genes could serve as an independent prognostic factor for patient survival (Di2021LncRNA; Dong2019Aberrant).

ZNF667 has also been studied in the context of angiogenesis, particularly after myocardial ischemia, where it promotes angiogenic processes through the Wnt signaling pathway (Wang2022ZNF667).

## Interactions
ZNF667, also known as zinc finger protein 667, is involved in several interactions with nucleic acids and proteins, playing a significant role in transcriptional regulation. ZNF667 acts as a transcriptional repressor by binding to the promoter of the Bax gene, a pro-apoptotic gene, thereby inhibiting its expression. This interaction is facilitated by the ZF2 region of ZNF667, which is necessary and sufficient for DNA binding. The binding is dependent on the core sequence CTTA, and mutations in this sequence disrupt the interaction (Jiang2014ZNF667Mipu1).

In addition to its interaction with the Bax promoter, ZNF667 also binds to the promoter of the anti-angiogenic gene VASH1, inhibiting its transcription. This interaction is crucial for promoting angiogenesis, particularly after myocardial ischemia, as it facilitates the invasion and tube formation of endothelial cells (Wang2022ZNF667).

ZNF667's role as a transcriptional repressor is further supported by its ability to recruit the corepressor KAP-1, which is mediated by its KRAB domain. This interaction contributes to its nuclear localization and repressive function (Jiang2014ZNF667Mipu1). These interactions highlight ZNF667's involvement in regulating apoptosis and angiogenesis through its binding to specific gene promoters.


## References


[1. (Wang2022ZNF667) Wenmei Wang, Weite Shang, Jiang Zou, Ke Liu, Meidong Liu, Xiaoqin Qiu, Huali Zhang, Kangkai Wang, and Nian Wang. Znf667 facilitates angiogenesis after myocardial ischemia through transcriptional regulation of vash1 and wnt signaling pathway. International Journal of Molecular Medicine, August 2022. URL: http://dx.doi.org/10.3892/ijmm.2022.5185, doi:10.3892/ijmm.2022.5185. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ijmm.2022.5185)

[2. (Dong2019Aberrant) Zhiming Dong, Shengmian Li, Xuan Wu, Yunfeng Niu, Xiaoliang Liang, Liu Yang, Yanli Guo, Supeng Shen, Jia Liang, and Wei Guo. Aberrant hypermethylation-mediated downregulation of antisense lncrna znf667-as1 and its sense gene znf667 correlate with progression and prognosis of esophageal squamous cell carcinoma. Cell Death &amp; Disease, December 2019. URL: http://dx.doi.org/10.1038/s41419-019-2171-3, doi:10.1038/s41419-019-2171-3. This article has 41 citations.](https://doi.org/10.1038/s41419-019-2171-3)

[3. (Di2021LncRNA) Riccardo Di Fiore, Sherif Suleiman, Rosa Drago-Ferrante, Ana Felix, Sharon A. O’Toole, John J. O’Leary, Mark P. Ward, James Beirne, Angel Yordanov, Mariela Vasileva-Slaveva, Yashwanth Subbannayya, Francesca Pentimalli, Antonio Giordano, and Jean Calleja-Agius. Lncrna mort (znf667-as1) in cancer—is there a possible role in gynecological malignancies? International Journal of Molecular Sciences, 22(15):7829, July 2021. URL: http://dx.doi.org/10.3390/ijms22157829, doi:10.3390/ijms22157829. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms22157829)

[4. (Chen2021ZNF667) Zhuang Chen, Haifen Liu, Yuanbin Li, Zhangfu Zhou, Jizhe Qiu, Yi Tang, and Taotao Cui. Znf667 attenuates leukocyte‐endothelial adhesion via downregulation of p‐selectin in skin flap following remote limb ischemic preconditioning. Cell Biology International, 45(7):1477–1486, March 2021. URL: http://dx.doi.org/10.1002/cbin.11586, doi:10.1002/cbin.11586. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/cbin.11586)

[5. (Jiang2014ZNF667Mipu1) Lei Jiang, Hao Wang, Chunli Shi, Ke Liu, Meidong Liu, Nian Wang, Kangkai Wang, Huali Zhang, Guiliang Wang, and Xianzhong Xiao. Znf667/mipu1 is a novel anti-apoptotic factor that directly regulates the expression of the rat bax gene in h9c2 cells. PLoS ONE, 9(11):e111653, November 2014. URL: http://dx.doi.org/10.1371/journal.pone.0111653, doi:10.1371/journal.pone.0111653. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0111653)

[6. (Meng2019Aberrant) Wenxia Meng, Weina Cui, Lei Zhao, Weiwei Chi, Huan Cao, and Baoshan Wang. Aberrant methylation and downregulation of znf667-as1 and znf667 promote the malignant progression of laryngeal squamous cell carcinoma. Journal of Biomedical Science, January 2019. URL: http://dx.doi.org/10.1186/s12929-019-0506-0, doi:10.1186/s12929-019-0506-0. This article has 48 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/s12929-019-0506-0)